Multidrug resistance (MDR-1) expression in aids-related lymphomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multidrug resistance (MDR-1) expression in aids-related lymphomas

Published:2002-02 Issue:2 Volume:26 Page:121-127
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Tulpule Anil,Sherrod Andy,Dharmapala Dharshika,Young Lillian L,Espina Byron M,Sanchez Maria Norilyn,Gill Parkash S,Levine Alexandra M

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference42 articles.

1. Molecular mechanisms of multidrug resistance in cancer chemotherapy;Nooter;Pathol. Res. Pract.,1996

2. Mechanisms of multidrug resistance and implications for therapy;Tsuruo;Jpn. J. Cancer Res.,1998

3. The biochemistry of p-glycoprotein-mediated multidrug resistance;Endicott;Annu. Rev. Biochem.,1989

4. Biochemistry of multidrug resistance mediated by the multidrug transporter;Gottesman;Annu. Rev. Biochem.,1993

5. The mdr1 gene, responsible for multidrug-resistance, codes for p-glycoprotein;Ueda;Biochem. Biophys. Res. Commun.,1986

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS) ‐associated lymphomas;British Journal of Haematology;2022-11-02

2. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial);Blood;2020-09-10

3. HIV virological failure in a patient with human T-lymphotropic virus type 1-associated leukemia;AIDS;2019-01-02

4. Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075);Clinical Lymphoma Myeloma and Leukemia;2018-03

5. Potential anti-MDR agents based on the podophyllotoxin scaffold: synthesis and antiproliferative activity evaluation against chronic myeloid leukemia cells by activating MAPK signaling pathways;RSC Advances;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3